MCMatheus Pileggi Camargo

Matheus Pileggi Camargo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matheus Pileggi Camargo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ANALYSIS OF A PREEMPTIVE ANTIBIOTIC THERAPY PROTOCOL IN INSTRUMENTED SPINAL ARTHRODESIS

    by Thomas Yi Teh Lee, Matheus Pileggi Camargo, Luana Caroline Kfouri Siqueira, Wesley Wilian Costa Martins, Leonardo Sardas, João Tomás Fernandes Castilho Garcia, Rodrigo Góes Medéa DE Mendonça, Alberto Gotfryd, Maria Fernanda Silber Caffaro, Renan Rodrigues Boldorini, et al.

    Objective: To describe the clinical profile and postoperative outcomes of patients undergoing instrumented spinal arthrodesis under a preemptive antibiotic therapy protocol with vancomycin and ciprofloxacin. Methods: A retrospective, consecutive, and single-center case series was conducted involving 88 patients operated on between January 2021 and December 2022. The protocol consisted of intravenous vancomycin (1 g) and ciprofloxacin (400 mg) administered 60 minutes before incision, with postoperative maintenance for five days. The minimum clinical follow-up was 24 months. Results: The mean age was 45.2 years, with a male predominance (60.2%). Trauma was the most frequent surgical indication (38.9%), followed by neoplasms (25%). The overall arthrodesis infection rate was 4.5% (4/88 patients), with 75% of these cases occurring in patients with oncological etiology. Only one adverse event (1.1%) related to vancomycin was recorded. Conclusions: The preemptive antibiotic therapy protocol showed favorable infection rates (4.5%) and good pharmacological tolerability in the studied sample, suggesting it is a viable strategy for high-complexity spine surgeries. Level of Evidence IV; Case series.